Autologous skin-derived neural precursor cell therapy reverses canine Alzheimer dementia-like syndrome in a proof of concept veterinary trial.
Michael ValenzuelaT DuncanA AbeyA JohnsonC BoulamatsisM A DaltonE JacobsonL BrunelG ChildD SimpsonM BucklandA LoweJ SietteF WestbrookP McGreevyPublished in: Stem cell research & therapy (2022)
With further development, SKN cell therapy may have potential for treating carefully chosen AD patients based on neurosynaptic restoration in the hippocampus.